JT
RXII

Jump Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jump Trading’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,685
Closed -$3K – 1210
2015
Q2 		$3K Buy
+1,685
New +$3K ﹤0.01% 1074

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Jump Trading's RXII Position: Q3 2015 in Review

Jump Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 1,685 shares — an estimated $3K sold.

Jump Trading first reported a position in RXII in Q2 2015 and held it in 1 quarter. The position peaked at $3K in Q2 2015. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

  • Jump Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
  • Jump Trading sold 1,685 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $3K.
  • Jump Trading first reported a position in GALENA BIOPHARMA INC COM in Q2 2015 and held it in 1 quarter.
  • Jump Trading's GALENA BIOPHARMA INC COM position peaked at $3K in Q2 2015.
  • 78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Jump Trading's 13F filing for Q3 2015, filed 16 Nov 2015.